Sentence examples for stage comparative analysis from inspiring English sources

Where important differences are identified, a second stage comparative analysis of process may be undertaken to identify components of the applied clinical practice processes that may be contributing to the estimated differences in costs and outcomes.

We used previously published human (Yan et al., 2013) and mouse (Deng et al., 2014) single-cell RNA-seq datasets as both include deep transcriptome profiling at comparable developmental stages, allowing comparative analysis of gene expression over time.

Stage 5 (2018): Qualitative comparative analysis (QCA) Stage 5 (2018): Qualitative comparative analysis (QCA) QCA provides an established method for comparing cases for generalisable findings about conditions, mechanisms and outcomes 48 and developing these as policy-relevant propositions.

To set the stage for the comparative analysis we briefly present the key elements of the two healthcare systems involved (Table 1).

The lead and support agencies must identify their ARARs related to specific actions in a timely manner and no later than the early stages of the comparative analysis.

Principal component analysis plots for leaf and cotyledon samples show consistency between biological replicates and significant differences between the stages selected for comparative analysis (Additional file 3).

In this stage we conducted a comparative analysis between the current and the proposed organisational process.

To explore the difference in gene expression between breeds at each developmental stage, we conducted a comparative analysis with the unpaired unequal variance t-test (Welch's t-test) method in GeneSpring10.0 (Agilent Technologies).

Stage 4. Undertake data synthesis and comparative analysis of stages 1-3.

This study provides a concise view of the global transcriptome of the L. major promastigote stage, providing the basis for future comparative analysis with other development stages or other Leishmania species.

Among 196 eligible patients with stage III disease, however, a comparative analysis of the two treatment groups suggested both an improvement in disease-free survival (P = 0.0014) and a survival advantage (P = 0.0005), with an estimated 43% reduction in mortality rate (95% confidence interval 26-70%) in favour of the investigational arm.